G. Paradisi et al., ENDOCRINE-METABOLIC FEATURES IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME DURING PREGNANCY, Human reproduction, 13(3), 1998, pp. 542-546
To elucidate the mechanism of metabolic adaptation of women with polyc
ystic ovary syndrome (PCOS) during pregnancy, the endocrine-metabolic
features of a group of PCOS patients with or without gestational diabe
tes were studied longitudinally during the three trimesters of gestati
on. Oral glucose tolerance test (OGTT, 100 g) and hyperinsulinaemic-eu
glycaemic clamp were performed throughout the study. Plasma concentrat
ions of insulin and glucose were determined by radioimmunoassay and gl
ucose oxidase technique, respectively. Five of 13 PCOS patients develo
ped gestational diabetes (GD) at the third trimester (PCOS-GD), while
the other eight patients did not develop any alteration of glucose met
abolism (PCOS-nGD). Both fasting glucose and insulin plasma concentrat
ions did not change significantly during pregnancy and no difference w
as seen between the two groups. On the contrary PCOS-GD group early ex
hibited higher values of area under the curve (AUC) for glucose and in
sulin response to OGTT with respect to those found in PCOS-nGD group,
This difference was already significant in the first gestational trime
ster, Moreover insulin sensitivity value (M) was significantly lower i
n the first trimester of gestation in PCOS-GD as compared with that fo
und in PCOS-nGD group. However, as gestation proceeded, M value decrea
sed in PCOS-nDG group and the difference from PCOS patients developing
gestational diabetes was not sustained into the second and third trim
esters, Both groups had similar body mass index values and AUC insulin
increase from first to third trimester of gestation. It is concluded
that early alteration of insulin sensitivity and secretion constitue s
pecific risk factors in PCOS patients for the development of abnormali
ties of glucose tolerance.